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Abstract 
Pleomorphic adenoma, also known as mixed
tumor, is a benign tumor which typically pres-
ents as a painless and persistent mass. The
majority of pleomorphic adenomas involve the
salivary  glands,  most  commonly  the  parotid
gland. Other sites include breast and skin. It is
a rare tumor in the vulva. In this article we are
reporting a case of pleomorphic adenoma of
labia with characteristic pathologic and clini-
cal findings, as reminder of a common benign
neoplasm occurring with rare locality.
Introduction
Pleomorphic adenoma, also known as mixed
tumor, is a benign tumor which typically pres-
ents as a painless, persistent mass.1 The major-
ity of pleomorphic adenomas involve the sali-
vary glands, most commonly the parotid gland.
Histologically,  these  tumors  are  encapsulated
and consist of epithelial (or myoepithelial) and
stromal  elements.  The  epithelial  component
may  form  a  variety  of  structures  including
tubules, ductules, or trabeculae, and the stromal
component  may  also  consist  of  a  variety  of
forms including mucoid, myxoid, cartilaginous,
and  osseous  elements.1,2 Pleomorphic  adeno-
mas may also occur at other sites including the
breast and skin (chondroid syringoma). When
not widely excised, pleomorphic adenomas may
reoccur.1,2
Pleomorphic adenoma of the vulva is rare,
and to date less than ten cases have been doc-
umented in the literature.1-5 Here, we report
another case of pleomorphic adenoma involv-
ing the vulva along with limited clinical follow-
up. The purpose of this report is to reiterate
and alert the clinicians about rare occurrences
including pleomorphic adenomas, a common
neoplasm of major salivary glands, in female
genital organs.
Case Report
A 64 year-old gravida 2 para 2 woman with a
longstanding history of prolapse of uterus as
well as pelvic pain presented for evaluation. The
patient initially had symptoms of urinary incon-
tinence with both stress and urinary urge symp-
toms. A workup revealed stage III anterior vagi-
nal prolapse, stage II uterocervical prolapse, and
vulvar contact dermatitis with a labial mass at
the site adjacent to vulva with dermatitis. The
tumor  was  presenting  as  a  solitary  round  to
oval, non-tender, and mobile mass. The patient
elected to proceed with surgical management
and consented to robotic-assisted vaginal hys-
terectomy, uterosacral vault suspension, diag-
nostic laparoscopy, retropubic sling placement,
cystoscopy, and excision of the left labial mass.
She did well after the operation and was dis-
charged on the first postoperative day. 
The excised labial mass consisted of a firm,
well circumscribed, ovoid piece of soft pink tis-
sue measuring 2.1¥1.0¥0.8 cm. The mass was
white and glistening with yellow discoloration
around  the  periphery  at  the  cut  surfaces.
Histologically, the mass showed a fibrous and
chondromyxoid  stroma  containing  epithelial
and  myoepithelial  cells  (Figure  1A).  The
epithelial  component  consisted  of  relatively
uniform appearing cells arranged in tubules
and  small  nested  aggregates  (Figure  1B).
Results  of  immunohistochemical  staining
were  consistent  with  pleomorphic  adenoma.
The epithelial component showed positivity for
keratin AE1/AE3 (Figure 1 C), CAM5.2 antigen,
epithelial  membrane  antigen  (EMA,  focal),
carcinoembryonic antigen (CEA, focal), and C-
KIT  gene  (scattered).  The  epithelial  compo-
nent was negative for p63 and smooth muscle
actin. The myoepithelial cells were focally pos-
itive for S100 and glial fibrillary acidic protein
(GFAP) as shown in Figure 1D.
Eleven months after excision of the vulvar
mass, at the time of writing this report, the
patient was free of recurrence.
Discussion
Pleomorphic  adenoma  (benign  mixed
tumor) is a commonly diagnosed benign tumor
in the salivary glands and may also occur at a
variety of other sites; however, it is a rare enti-
ty in the vulva. There are only ten cases report-
ed in the literature to date. Of the ten reported
cases, one had a carcinoma arising in a pleo-
morphic  adenoma,  but  remaining  cases  had
been benign.1 Malignant transformation rate
of pleomorphic adenoma has been described
for other topographic sites of the origin.6-8
Pleomorphic adenoma is the most common
salivary gland tumor and accounts for 60% of
all  salivary  gland  neoplasms.9 About  80%  of
pleomorphic adenomas arise in parotid gland,
10% in the submandibular gland, and 10% in
the  minor  salivary  glands  of  the  oral  cavity,
paranasal sinuses, and the upper respiratory
and alimentary tract.10 Pleomorphic adenomas
are  usually  slow  growing  solitary  painless
tumors.  They  are  often  encapsulated,  well-
defined ovoid or round masses. In minor sali-
vary glands they have a poorly developed or
absent  capsule.11 Histologically,  pleomorphic
adenoma shows a remarkable degree of mor-
phologic diversity. The essential components
are the epithelial, myoepithelial, and stromal
or mesenchymal elements. The epithelial com-
ponent shows a variety of cell types including
cuboidal,  basaloid,  squamous,  spindle  cell,
plasmacytoid, and clear cells. These cells are
cytologically  bland  without  atypia  or  mitotic
figures.  These  cells  usually  form  sheets  or
duct-like  structures.  The  cellularity  of  the
epithelial component also varies. Sometimes
the  epithelial  cells  form  the  majority  of  the
tumor, also known as cellular pleomorphic ade-
noma. This type of cellularity in the tumors
bears  no  significant  in  prognosis.  Myoepi  -
thelial cells may form a fine reticular pattern
or  sheets  of  spindle-shaped  or  plasmacytoid
cells.  The  mesenchymal  component  can  be
myxoid/mucoid,  cartilaginous  or  hyalinised.
Cells within the myxoid material are myoep-
ithelial cells in origin and tend to blend into
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the surrounding stroma. Immunohistochemi-
cally,  the  inner  ductal  cells  are  positive  for
cytokeratin. The myoepithelial cells are vari-
ably positive for S-100 protein, smooth muscle
actin,  GFAP,  calponin,  and  CD10.12 Although
pleomorphic adenoma is a benign tumor it can
cause problems in clinical management due to
its  tendency  to  recur  and  risk  of  malignant
transformation.  Recurrences  rate  in  parotid
gland  tumors  is  3.4%  after  5  years.13
Pleomorphic adenomas have tendency to reoc-
cur  when  not  widely  excised,  particularly  if
they are i) predominantly mucoid,14 ii) have
variability of the thickness of the capsule and
the tumor invading through the capsule,15 and
iii) due to low biological requirements the neo-
plastic  cells  can  survive  when  spilt  into  the
operative sites.12
Pleomorphic  adenoma  is  a  benign  tumor
found rarely in the breast but commonly in the
salivary glands. Unlike the salivary gland vari-
ant, the guidelines for the management of the
tumor are poorly defined for occurrences in the
breast.  Due  to  the  risk  of  recurrence  and
malignant transformation of pleomorphic ade-
nomas of the breast, complete excision of the
lesion with a cuff of normal tissue is recom-
mended,  as  is  the  practice  in  the  salivary
gland.16 Mixed tumors of the vagina appear to
be a distinct and unrelated entity to pleomor-
phic adenoma of the vulva. Mixed tumors of
the  vagina  are  composed  predominantly  of
spindle  cells  admixed  with  minor  glandular
and focal areas of squamous differentiation.
There has been no myoepithelial differentia-
tion reported in vaginal mixed tumors.17-19
The exact histogenesis of vulvar pleomor-
phic  adenomas  has  not  been  determined.  It
has been suggested that pleomorphic adeno-
mas  may  arise  from  Bartholin’s  or  other
vestibular glands, sweat glands of the vulva, or
anogenital  mammary-like  glands.4 Given  the
paucity of reported cases, the exact biologic
potential of vulvar pleomorphic adenomas is
difficult to determine. As in this patient, most
reported cases of vulvar pleomorphic adeno-
mas were located in the left labium.1,2,5 No pre-
existing  lesions  have  been  described  in  the
previously reported cases. Most of the reported
cases were in postmenopausal women as in
our case.2 However, given the histologic and
immunologic similarity of vulvar pleomorphic
adenoma to pleomorphic adenoma occurring
at other sites, it is reasonable to speculate that
the pleomorphic adenomas of the vulva behave
in a similar manner to pleomorphic adenomas
elsewhere. Due to lack of clinical experience in
this type of vulvar neoplasm, clinical manage-
ment is driven from other organs. Extensive
surgical excision with clear margin is the sin-
gle therapeutic option. As a consequent recur-
rence  possibility  and  malignant  transforma-
tion in this tumor, a long term follow up is rec-
ommended.3 As more cases are reported with
clinical follow-up, the natural history of these
tumors will be better understood. In this case,
we recommended frequent and careful follow
ups to determine if complete excision has been
achieved.
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